GlaxoSmithKline | 销售成本



Cost Of Sales 更改 日
AbbVie USD 4B 394M 2025-03
Alcon AG USD 1.12B 34M 2024-12
Almirall EUR 16.73M 73.47M 2024-06
Amgen USD 2.6B 507M 2025-03
argenx SE USD 72.66M 222.35M 2024-12
AstraZeneca USD 2.24B 484M 2025-03
Bayer EUR 5.72B 633M 2024-12
Biogen USD 629.3M 45.8M 2025-03
Bristol-Myers Squibb USD 3.03B 179M 2025-03
Eli Lilly USD 2.22B 179.6M 2025-03
Fresenius EUR 4.24B 25M 2025-03
Fresenius Medical Care EUR 3.7B 117M 2025-03
Galapagos EUR 13.73M 99.2M 2025-03
Genmab DKK 337M 64M 2024-12
Gilead Sciences USD 1.54B 41M 2025-03
GlaxoSmithKline GBP 1.92B 635M 2025-03
Glaxosmithkline GBP 2.52B 199M 2024-12
GRIFOLS EUR 1.21B 143.12M 2024-12
Hikma Pharmaceutical USD 813M 39M 2024-06
Lonza CHF 1.94B 858M 2024-06
Merck EUR 2.32B 197M 2024-12
Merck USD 2.76B 944M 2025-03
Novartis USD 3.32B 90M 2024-12
Novo Nordisk 12.89B 1.58B 2025-03
Orion EUR 152.8M 14.3M 2025-03
Pfizer USD 2.59B 3.06B 2025-03
Philips EUR 2.25B 833M 2025-03
Recordati EUR 172.29M 19.33M 2024-09
Regeneron Pharmaceuticals USD 265.5M 299.9M 2025-03
Roche Holding CHF 4.13B 393.5M 2024-12
Sanofi EUR 2.89B 618M 2025-03
Smith & Nephew USD 911M 58M 2024-12
UCB EUR 425.5M 479.5M 2024-06



GlaxoSmithKline 销售成本 - 当前值，历史数据，预测，统计，图表和经济日历 - May 2025.